LA 419
| Code | Size | Price |
|---|
| TAR-T32513-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
LA 419 is a nitric oxide donor.
CAS:
263754-97-8
Formula:
C14H18N2O7S
Molecular Weight:
358.37
Purity:
0.98
SMILES:
CCSC1NC=CC=C1C(=O)O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O
References
1. Mourelle M, Martin MT, Gim?nez F. Treatment with LA-419 prevents monocrotaline-induced pulmonary hypertension and lung injury in the rat. Proc West Pharmacol Soc. 2011;54:89-93. PubMed PMID: 22423590.
2. Megson IL, Leslie SJ. LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders. Curr Opin Investig Drugs. 2009 Mar;10(3):276-85. Review. PubMed PMID: 19333886.
3. Mart?nez-Murillo R, Fern?ndez AP, Serrano J, Rodrigo J, Salas E, Mourelle M, Mart?nez A. The nitric oxide donor LA 419 decreases brain damage in a focal ischemia model. Neurosci Lett. 2007 Mar 26;415(2):149-53. Epub 2007 Jan 7. PubMed PMID: 17239538.
4. Serrano J, Fern?ndez AP, Mart?nez-Murillo R, Alonso D, Rodrigo J, Salas E, Mourelle M, Mart?nez A. The nitric oxide donor LA 419 decreases ischemic brain damage. Int J Mol Med. 2007 Feb;19(2):229-36. PubMed PMID: 17203196.